相关实验视频

Updated: Jul 24, 2025

Isolation of Human Primary Valve Cells for In vitro Disease Modeling

Isolation of Human Primary Valve Cells for In vitro Disease Modeling

Published on: April 16, 2021

在膜间歇细胞中PAI-1过度表达有助于大动脉狭窄症中的低纤维素解

Magdalena Kopytek^1,2, Michał Ząbczyk^1,2, Piotr Mazur^3,4

¹Thromboembolic Disorders Department, Institute of Cardiology, Jagiellonian University Medical College, 80 Pradnicka St., 31-202 Krakow, Poland.

|July 6, 2023

概括

在大动脉狭窄时,高的LDL胆固醇会增加PAI-1,这是一种阻碍凝块分解的蛋白质. 这有助于减少纤维素分解和疾病严重程度.

科学领域:

心血管生物学心血管生物学
血液静止和血栓形成
分子医学是分子医学.

背景情况:

大动脉狭窄 (AS) 与低纤维素分解有关,这种情况会损害血块的分解,但潜在的机制仍然不清楚.
低密度脂蛋白 (LDL) 胆固醇在这个过程中的作用,特别是它对等离子体激活剂抑制剂1 (PAI-1) 的作用,需要进一步研究.

研究的目的:

为了研究LDL胆固醇,PAI-1表达和严重大动脉狭窄症患者的低纤维素溶解之间的关系.
阐明核因子-kappa B (NF-κB) 途径在中介PAI-1表达在大动脉间歇细胞 (VICs) 中的作用.

主要方法:

分析PAI-1,NF-κB和脂质积累在狭窄性大动脉的75名患者与5名对照组相比.
实验室研究评估PAI-1表达和纤维溶解能力在VICs刺激的LDL,使用PAI-1和NF-κB抑制剂.

主要成果:

PAI-1表达仅在AS门中检测到,与脂质积累和疾病严重程度相关,并与NF-κB共同局部化.
对VICs的LDL刺激增加了PAI-1水平和延长的凝块溶解时间 (CLT),表明纤维素分解减少.
抑制PAI-1或NF-κB恢复了正常的CLT,而NF-κB抑制减少了PAI-1和SERPINE1的表达.

结论:

在严重的AS中,脂质积累驱动了膜PAI-1的过度表达,导致低纤维素分解和疾病进展.
NF-κB途径参与调节AS中的PAI-1表达,提供潜在的治疗点.

关键词:

这就是为什么LDL,LDL是LDL.大动脉狭窄症 (大动脉狭窄症)纤维化解是一种纤维化解.核因子卡帕 B B 核因子塑原激活剂抑制剂 1 塑原激活剂抑制剂门间歇细胞的间歇细胞

更多相关视频

A Rabbit Aortic Valve Stenosis Model Induced by Direct Balloon Injury

A Rabbit Aortic Valve Stenosis Model Induced by Direct Balloon Injury

Published on: March 31, 2023

Isolation and Characterization of Primary Rat Valve Interstitial Cells: A New Model to Study Aortic Valve Calcification

Isolation and Characterization of Primary Rat Valve Interstitial Cells: A New Model to Study Aortic Valve Calcification

Published on: November 20, 2017

相关概念视频

Mitral Valve Prolapse I: Introduction

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...

Mitral Stenosis I: Introduction

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...